Beranda › Fibrosis Paru Idiopatik › Kansas › Kansas City
Uji klinis Fibrosis Paru Idiopatik di Kansas City, KS
7 studi untuk Fibrosis Paru Idiopatik mencari peserta di lokasi sekitar Kansas City (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
Menerima pesertaFase 2
- The University of Kansas Medical Center, Kansas City
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
Menerima pesertaFase 2
- Research Site, Kansas City
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Menerima pesertaFase 2
- The University of Kansas Medical Center, Kansas City
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
Menerima pesertaFase 2
- University of Kansas Medical Center, Kansas City
Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Menerima pesertaFase 2
- University of Kansas, Kansas City
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Menerima pesertaFase 2
- WISPer site in Kansas City, KS, Kansas City
Interstitial Lung Disease Research Unit Biobank
Menerima pesertaStudi observasional
- The University of Kansas Medical Center, Kansas City
Uji klinis Fibrosis Paru Idiopatik di kota lain
- Birmingham, AL9 studi
- New York City, NY8 studi
- Los Angeles, CA7 studi
- Philadelphia, PA7 studi
- Chicago, IL6 studi
- Aurora, CO6 studi
- Durham, NC6 studi
- Nashville, TN5 studi
- Dallas, TX5 studi
- Charleston, SC5 studi
- Houston, TX5 studi
- Atlanta, GA5 studi
Studi lain di Kansas City
- Penyakit Kardiovaskular14 studi
- Gagal Jantung13 studi
- Obesitas13 studi
- Penyakit Paru Interstisial13 studi
- Fibrosis Kistik13 studi
- Kanker Payudara12 studi
- Kanker Kandung Kemih12 studi
- Leukemia Mieloid Akut12 studi
- Kanker Prostat12 studi
- Kanker Paru Non-Sel Kecil11 studi
- Kanker Paru11 studi
- PPOK9 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.